Adverum Historical Cash Flow

ADVM Stock  USD 14.66  0.51  3.60%   
Analysis of Adverum Biotechnologies cash flow over time is an excellent tool to project Adverum Biotechnologies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 13.5 M or Begin Period Cash Flow of 97.8 M as it is a great indicator of Adverum Biotechnologies ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Adverum Biotechnologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Adverum Biotechnologies is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

About Adverum Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Adverum balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Adverum's non-liquid assets can be easily converted into cash.

Adverum Biotechnologies Cash Flow Chart

Adverum Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Adverum Biotechnologies Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Adverum Biotechnologies' Change Receivables is very stable compared to the past year. As of the 28th of March 2024, Total Cashflows From Investing Activities is likely to grow to about 171.1 M, while Stock Based Compensation is likely to drop about 13.5 M.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Adverum Biotechnologies to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Adverum Biotechnologies operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Adverum Biotechnologies' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.At this time, Adverum Biotechnologies' Change Receivables is very stable compared to the past year. As of the 28th of March 2024, Total Cashflows From Investing Activities is likely to grow to about 171.1 M, while Stock Based Compensation is likely to drop about 13.5 M.

Adverum Biotechnologies cash flow statement Correlations

0.040.180.18-0.48-0.110.13-0.290.080.420.390.580.050.25-0.310.280.380.63-0.270.030.020.02
0.04-0.940.30.280.830.250.6-0.930.32-0.080.10.370.270.66-0.83-0.76-0.630.650.510.330.04
0.18-0.94-0.24-0.27-0.93-0.33-0.660.95-0.090.230.09-0.25-0.36-0.790.860.860.73-0.74-0.66-0.230.1
0.180.3-0.24-0.190.13-0.620.57-0.230.00.350.210.3-0.20.02-0.02-0.14-0.040.30.00.050.33
-0.480.28-0.27-0.190.140.010.19-0.360.58-0.4-0.160.13-0.070.13-0.67-0.34-0.750.13-0.150.47-0.04
-0.110.83-0.930.130.140.520.4-0.910.01-0.2-0.120.140.430.77-0.76-0.77-0.640.70.850.19-0.15
0.130.25-0.33-0.620.010.52-0.3-0.340.07-0.2-0.05-0.120.480.51-0.36-0.37-0.170.180.66-0.02-0.31
-0.290.6-0.660.570.190.4-0.3-0.53-0.06-0.01-0.030.3-0.040.46-0.51-0.58-0.530.710.190.070.08
0.08-0.930.95-0.23-0.36-0.91-0.34-0.53-0.270.170.15-0.21-0.41-0.630.860.750.69-0.67-0.62-0.50.08
0.420.32-0.090.00.580.010.07-0.06-0.27-0.050.380.180.13-0.18-0.410.02-0.18-0.14-0.180.510.0
0.39-0.080.230.35-0.4-0.2-0.2-0.010.17-0.050.350.18-0.33-0.240.410.270.380.08-0.08-0.040.38
0.580.10.090.21-0.16-0.12-0.05-0.030.150.380.350.11-0.1-0.010.120.150.17-0.09-0.02-0.430.0
0.050.37-0.250.30.130.14-0.120.3-0.210.180.180.11-0.660.21-0.31-0.25-0.140.50.04-0.010.88
0.250.27-0.36-0.2-0.070.430.48-0.04-0.410.13-0.33-0.1-0.660.17-0.25-0.16-0.06-0.140.40.25-0.84
-0.310.66-0.790.020.130.770.510.46-0.63-0.18-0.24-0.010.210.17-0.7-0.94-0.680.620.64-0.25-0.07
0.28-0.830.86-0.02-0.67-0.76-0.36-0.510.86-0.410.410.12-0.31-0.25-0.70.830.86-0.56-0.43-0.350.07
0.38-0.760.86-0.14-0.34-0.77-0.37-0.580.750.020.270.15-0.25-0.16-0.940.830.81-0.63-0.5-0.030.01
0.63-0.630.73-0.04-0.75-0.64-0.17-0.530.69-0.180.380.17-0.14-0.06-0.680.860.81-0.57-0.35-0.220.1
-0.270.65-0.740.30.130.70.180.71-0.67-0.140.08-0.090.5-0.140.62-0.56-0.63-0.570.660.080.3
0.030.51-0.660.0-0.150.850.660.19-0.62-0.18-0.08-0.020.040.40.64-0.43-0.5-0.350.66-0.07-0.18
0.020.33-0.230.050.470.19-0.020.07-0.50.51-0.04-0.43-0.010.25-0.25-0.35-0.03-0.220.08-0.070.02
0.020.040.10.33-0.04-0.15-0.310.080.080.00.380.00.88-0.84-0.070.070.010.10.3-0.180.02
Click cells to compare fundamentals

Adverum Biotechnologies Account Relationship Matchups

Adverum Biotechnologies cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash(89.1M)(3.5M)(26.7M)34.2M6.6M5.1M
Stock Based Compensation9.9M20.4M25.2M20.1M17.6M13.5M
Free Cash Flow(68.4M)(91.1M)(123.0M)(119.9M)(92.1M)(87.5M)
Change In Working Capital5.1M12.7M4.1M19.9M(8.3M)(7.9M)
Begin Period Cash Flow155.9M66.9M63.4M36.7M68.4M97.8M
Other Cashflows From Financing Activities2.4M11.7M952K14.2M96.9M101.7M
Depreciation1.6M4.2M4.6M6.5M5.6M5.9M
Other Non Cash Items58K75K(25K)(51K)10.6M11.1M
Capital Expenditures19.2M11.8M15.1M11.8M808K767.6K
Total Cash From Operating Activities(49.2M)(79.3M)(107.8M)(108.1M)(91.3M)(86.8M)
Net Income(64.5M)(117.5M)(145.5M)(154.5M)(117.2M)(123.0M)
Total Cash From Financing Activities28.2M356.0M2.4M607K489K464.6K
End Period Cash Flow66.9M63.4M36.7M70.9M75M76.2M
Change To Liabilities1.3M6.8M1.7M845K760.5K722.5K
Sale Purchase Of Stock71.2M29.8M358.1M2.6M3.0M2.9M
Investments(48.8M)(268.3M)93.8M141.7M96.9M101.7M
Total Cashflows From Investing Activities(68.1M)(280.2M)78.7M141.7M163.0M171.1M
Cash And Cash Equivalents Changes85.4M(89.1M)(3.5M)(26.7M)(24.1M)(22.8M)
Cash Flows Other Operating(1.8M)3.8M5.9M2.4M2.8M2.9M
Change To Operating Activities5.7M11.1M5.7M19.0M21.9M23.0M
Change To Netincome9.9M20.8M26.2M20.0M18.0M17.6M

Pair Trading with Adverum Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adverum Stock

  0.74EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Adverum Stock

  0.75VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.75CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.66MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.56MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
  0.56PFE Pfizer Inc Fiscal Quarter End 31st of March 2024 PairCorr
The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.
The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Adverum Stock analysis

When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.60)
Revenue Per Share
0.357
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.32)
Return On Equity
(0.88)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.